Skip to main content
. 2016 Sep 14;3(4):ofw191. doi: 10.1093/ofid/ofw191

Table 4.

Treatments and Outcomes

Cases (n = 162) Control (n = 88) P Valuea
n (%) n (%)
Preculture Antimicrobials
 None 6 (3.7%) 61 (69.3%) <.001
 Vancomycin 126 (77.8%) 16 (18.2%) <.001
 Piperacillin/Tazobactam 49 (30.3%) 8 (9.1%) <.001
 Carbapenem 5 (3.1%) 0 (0.0%) .17
 Cefepime 10 (6.2%) 1 (1.1%) .10
 Ceftriaxone 41 (25.3%) 4 (4.6% <.001
 Other 49 (30.3%) 13 (14.8%) .009
Time to empiric antimicrobial in hours (median, IQR) 11.1 (6.0–26.3) 9.1 (3.7–22.4) .40
Treatmentsb
 None 1 (0.6%) 53 (60.2%) <.001
 Antibiotics only 64 (39.5%) 11 (12.5%)
 Surgery only 1 (0.6%) 17 (19.3%)
 Antibiotics and surgery 96 (59.3%) 7 (8.0%)
Discharge Disposition
 Death 13 (8.0%) 5 (5.7%) .09
 Home 47 (29.0%) 39 (44.3%)
 Skilled nursing/long-term care facility 99 (61.1%) 42 (47.7%)
 Against medical advice 3 (1.9%) 2 (2.3%)

Abbreviations: IQR, interquartile range; IR, interventional radiology.

a Kruskal-Wallis equality of populations rank test (continuous) or Fisher's exact (categorical) test. The null hypothesis for all tests is that means or proportions are equal in cases and controls.

b Surgery consisting of 1 or more of the following: neurosurgical debridement/drainage; IR-guided needle aspiration; spinal fusion; disc replacement; laminectomy; discectomy; foraminotomy.